查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387032

女性健康检查市场报告：2030年趋势、预测与竞争分析

Womens Health Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

女性健康检查趋势及预测

预计到 2030 年，全球女性健康诊断市场将达到 488.2 亿美元，2024 年至 2030 年年复合成长率为 8.1%。该市场的主要驱动力是女性感染疾病的高盛行率以及 POC 检测的不断增长的迹象。全球女性健康诊断市场的未来前景广阔，医院/诊所、诊断/影像中心和家庭护理市场存在商机。

女性健康诊断市场洞察

Lucintel 预测，由于乳癌的高发生率以及人们对 ABS 等先进乳癌诊断技术的认识不断增强，预计乳癌在预测期内将出现最高增长。

由于使用自检检测套组的好处越来越多，居家医疗仍然是市场上最大的部分。

由于女性癌症盛行率不断上升，预计北美在预测期内将经历最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球女性健康诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球女性健康检查市场趋势（2018-2023）及预测（2024-2030）
  • 按最终用途产业分類的全球女性健康诊断市场
    • 医院和诊所
    • 诊断中心及影像中心
    • 居家照护
    • 其他的
  • 全球女性健康诊断市场（按应用）
    • 骨质疏鬆测试
    • OVC测试
    • 子宫颈癌测试
    • 乳癌检查
    • 妊娠及不孕症检测
    • 产前基因筛检和基因带原检测
    • 传染病检查
    • 性病测试
    • 超音波检查

第4章2018-2030年分地区市场趋势及预测分析

  • 全球女性健康检查市场（按地区）
  • 北美女性健康检查市场
  • 欧洲女性健康检查市场
  • 亚太女性健康检查市场
  • 其他地区女性健康体检市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球女性健康诊断市场最终用途产业的成长机会
    • 全球女性健康诊断市场的成长机会（按应用）
    • 按地区分類的全球女性健康诊断市场成长机会
  • 全球女性健康检查市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球女性健康诊断市场的容量
    • 全球女性健康诊断市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • F. Hoffmann-la Roche
  • Siemens Aktiengesellschaft
  • Quest Diagnostics Incorporated
  • Ge Healthcare
  • Koninklijke Philips
  • General Motors
  • Abbott Laboratories
  • Becton
  • Dickinson
  • Hologic
简介目录

Womens Health Diagnostic Trends and Forecast

The future of the global womens health diagnostic market looks promising with opportunities in the hospitals & clinics, diagnostic and imaging centers, and home care settings markets. The global womens health diagnostic market is expected to reach an estimated $48.82 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are high prevalence of infectious diseases in women and growing adaption of POC dignostic testing.

A more than 150-page report is developed to help in your business decisions.

Womens Health Diagnostic by Segment

The study includes a forecast for the global womens health diagnostic by end use industry, application, and region.

Womens Health Diagnostic Market by End Use Industry Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Diagnostic & Imaging Centers
  • Home Care Settings
  • Others

Womens Health Diagnostic Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Osteoporosis Testing
  • OVC Testing
  • Cervical Cancer Testing
  • Breast Cancer Testing
  • Pregnancy & Fertility Testing
  • Prenatal Genetic Screening & Carrier Testing
  • Infectious Disease Testing
  • STD Testing
  • Ultrasound Tests
  • Others

Womens Health Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Womens Health Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies womens health diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the womens health diagnostic companies profiled in this report include-

  • F. Hoffmann-La Roche
  • Siemens Aktiengesellschaft
  • Quest Diagnostics Incorporated
  • GE Healthcare
  • Koninklijke Philips
  • General Motors
  • Abbott Laboratories
  • Becton
  • Dickinson
  • Hologic

Womens Health Diagnostic Market Insights

Lucintel forecasts that breast cancer is expected to witness highest growth over the forecast period due to high occurrence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques, such as abus.

Within this market, home care settings will remain the largest segment due to increasing advantages of using self-testing kits.

North America is expected to witness highest growth over the forecast period due to increasing prevalence of cancer among women.

Features of the Global Womens Health Diagnostic Market

Market Size Estimates: Womens health diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Womens health diagnostic market size by end use industry, application, and region in terms of value ($B).

Regional Analysis: Womens health diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different end use industry, application, and regions for the womens health diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the womens health diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the womens health diagnostic market size?

Answer: The global womens health diagnostic market is expected to reach an estimated $48.82 billion by 2030.

Q.2 What is the growth forecast for womens health diagnostic market?

Answer: The global womens health diagnostic market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the womens health diagnostic market?

Answer: The major drivers for this market are high prevalence of infectious diseases in women and growing adaption of POC dignostic testing.

Q4. What are the major segments for womens health diagnostic market?

Answer: The future of the womens health diagnostic market looks promising with opportunities in the hospitals & clinics, diagnostic and imaging centers, and home care settings markets.

Q5. Who are the key womens health diagnostic market companies?

Answer: Some of the key womens health diagnostic companies are as follows:

  • F. Hoffmann-La Roche
  • Siemens Aktiengesellschaft
  • Quest Diagnostics Incorporated
  • Ge Healthcare
  • Koninklijke Philips
  • General Motors
  • Abbott Laboratories
  • Becton
  • Dickinson
  • Hologic

Q6. Which womens health diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that breast cancer is expected to witness highest growth over the forecast period due to high occurrence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques, such as abus.

Q7. In womens health diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to increasing prevalence of cancer among women.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the womens health diagnostic market by end use industry (hospitals & clinics, diagnostic & imaging centers, home care settings, and others), application (osteoporosis testing, ovc testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Womens Health Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Womens Health Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Womens Health Diagnostic Market by End Use Industry Industry
    • 3.3.1: Hospitals & Clinics
    • 3.3.2: Diagnostic & Imaging Centers
    • 3.3.3: Home Care Settings
    • 3.3.4: Others
  • 3.4: Global Womens Health Diagnostic Market by Application
    • 3.4.1: osteoporosis testing
    • 3.4.2: OVC testing
    • 3.4.3: cervical cancer testing
    • 3.4.4: breast cancer testing
    • 3.4.5: pregnancy & fertility testing
    • 3.4.6: prenatal genetic screening & carrier testing
    • 3.4.7: infectious disease testing
    • 3.4.8: STD testing
    • 3.4.9: ultrasound tests

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Womens Health Diagnostic Market by Region
  • 4.2: North American Womens Health Diagnostic Market
    • 4.2.2: North American Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others
  • 4.3: European Womens Health Diagnostic Market
    • 4.3.1: European Womens Health Diagnostic Market by End Use Industry Industry: Hospitals & Clinics, Diagnostic & Imaging Centers, Home Care Settings, and Others
    • 4.3.2: European Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others
  • 4.4: APAC Womens Health Diagnostic Market
    • 4.4.1: APAC Womens Health Diagnostic Market by End Use Industry Industry: Hospitals & Clinics, Diagnostic & Imaging Centers, Home Care Settings, and Others
    • 4.4.2: APAC Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others
  • 4.5: ROW Womens Health Diagnostic Market
    • 4.5.1: ROW Womens Health Diagnostic Market by End Use Industry Industry: Hospitals & Clinics, Diagnostic & Imaging Centers, Home Care Settings, and Others
    • 4.5.2: ROW Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Womens Health Diagnostic Market by End Use Industry Industry
    • 6.1.2: Growth Opportunities for the Global Womens Health Diagnostic Market by Application
    • 6.1.3: Growth Opportunities for the Global Womens Health Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Womens Health Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Womens Health Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Womens Health Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: F. Hoffmann-la Roche
  • 7.2: Siemens Aktiengesellschaft
  • 7.3: Quest Diagnostics Incorporated
  • 7.4: Ge Healthcare
  • 7.5: Koninklijke Philips
  • 7.6: General Motors
  • 7.7: Abbott Laboratories
  • 7.8: Becton
  • 7.9: Dickinson
  • 7.10: Hologic